566 related articles for article (PubMed ID: 32076273)
1. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Moral JA; Leung J; Rojas LA; Ruan J; Zhao J; Sethna Z; Ramnarain A; Gasmi B; Gururajan M; Redmond D; Askan G; Bhanot U; Elyada E; Park Y; Tuveson DA; Gönen M; Leach SD; Wolchok JD; DeMatteo RP; Merghoub T; Balachandran VP
Nature; 2020 Mar; 579(7797):130-135. PubMed ID: 32076273
[TBL] [Abstract][Full Text] [Related]
2. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
[TBL] [Abstract][Full Text] [Related]
3. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Ma Y; Li J; Wang H; Chiu Y; Kingsley CV; Fry D; Delaney SN; Wei SC; Zhang J; Maitra A; Yee C
Gastroenterology; 2020 Jul; 159(1):306-319.e12. PubMed ID: 32179091
[TBL] [Abstract][Full Text] [Related]
4. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
[TBL] [Abstract][Full Text] [Related]
5. Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
Burrack AL; Spartz EJ; Raynor JF; Wang I; Olson M; Stromnes IM
Cell Rep; 2019 Aug; 28(8):2140-2155.e6. PubMed ID: 31433988
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
7. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway.
Pu N; Gao S; Yin H; Li JA; Wu W; Fang Y; Zhang L; Rong Y; Xu X; Wang D; Kuang T; Jin D; Yu J; Lou W
Cancer Lett; 2019 Sep; 460():42-53. PubMed ID: 31233838
[TBL] [Abstract][Full Text] [Related]
8. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
9. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Jacquelot N; Seillet C; Wang M; Pizzolla A; Liao Y; Hediyeh-Zadeh S; Grisaru-Tal S; Louis C; Huang Q; Schreuder J; Souza-Fonseca-Guimaraes F; de Graaf CA; Thia K; Macdonald S; Camilleri M; Luong K; Zhang S; Chopin M; Molden-Hauer T; Nutt SL; Umansky V; Ciric B; Groom JR; Foster PS; Hansbro PM; McKenzie ANJ; Gray DHD; Behren A; Cebon J; Vivier E; Wicks IP; Trapani JA; Munitz A; Davis MJ; Shi W; Neeson PJ; Belz GT
Nat Immunol; 2021 Jul; 22(7):851-864. PubMed ID: 34099918
[TBL] [Abstract][Full Text] [Related]
11. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
12. PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma.
Howard E; Hurrell BP; Helou DG; Quach C; Painter JD; Shafiei-Jahani P; Fung M; Gill PS; Soroosh P; Sharpe AH; Akbari O
Front Immunol; 2021; 12():733136. PubMed ID: 34531874
[TBL] [Abstract][Full Text] [Related]
13. Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.
Morrison AH; Diamond MS; Hay CA; Byrne KT; Vonderheide RH
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8022-8031. PubMed ID: 32213589
[TBL] [Abstract][Full Text] [Related]
14. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
15. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8
Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H
Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004
[TBL] [Abstract][Full Text] [Related]
16. IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Somani VK; Zhang D; Dodhiawala PB; Lander VE; Liu X; Kang LI; Chen HP; Knolhoff BL; Li L; Grierson PM; Ruzinova MB; DeNardo DG; Lim KH
Gastroenterology; 2022 Jun; 162(7):2047-2062. PubMed ID: 35271824
[TBL] [Abstract][Full Text] [Related]
17. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
Front Immunol; 2021; 12():680055. PubMed ID: 34194433
[TBL] [Abstract][Full Text] [Related]
18. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice.
Drake LY; Iijima K; Bartemes K; Kita H
J Immunol; 2016 Aug; 197(4):1335-42. PubMed ID: 27421480
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer.
Zhao J; Wen X; Tian L; Li T; Xu C; Wen X; Melancon MP; Gupta S; Shen B; Peng W; Li C
Nat Commun; 2019 Feb; 10(1):899. PubMed ID: 30796212
[TBL] [Abstract][Full Text] [Related]
20. Sepsis Induces Deregulation of IL-13 Production and PD-1 Expression in Lung Group 2 Innate Lymphoid Cells.
Akama Y; Park EJ; Satoh-Takayama N; Gaowa A; Ito A; Kawamoto E; Darkwah S; Appiah MG; Myint PK; Ohno H; Imai H; Shimaoka M
Shock; 2021 Mar; 55(3):357-370. PubMed ID: 32826811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
